NCT03027388 2023-11-22Protein Phosphatase 2A Inhibitor, in Recurrent GlioblastomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed7 enrolled 20 charts
NCT01837667 2017-01-24Phase I Study of LB-100 With Docetaxel in Solid TumorsLixte Biotechnology Holdings, Inc.Phase 1 Completed29 enrolled